$40.78
1.39%
NYSE, Nov 04, 04:00 pm EST. Closed.
ISIN
BMG3922B1072
Symbol
G

Genpact Limited Stock price

$40.78
+7.26 21.66% 1M
+6.64 19.45% 6M
-6.00 12.83% YTD
+2.35 6.12% 1Y
+6.31 18.31% 3Y
-9.81 19.39% 5Y
+17.30 73.68% 10Y
+26.05 176.88% 20Y
NYSE, Closing price Wed, Nov 04 2026
+0.56 1.39%

Is Genpact Limited a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,093 stocks worldwide.

Key metrics

Basic
Market capitalization
$6.7b
Enterprise Value
$7.4b
Net debt
$676.8m
Cash
$520.7m
Shares outstanding
168.0m
Valuation
P/E
11.8
P/S | estimate
1.3 | 1.2
EV/Sales | estimate
1.4 | 1.3
EV/FCF | ex SBC
13.5 | 16.4
P/B
2.6
Dividends
DPS
$0.75
Yield 1Y | 5Y
1.9% | 1.5%
Growth 1Y | 5Y
10.3% | 11.8%
Payout 1Y | 3Y
21.7% | 19.6%
Increased
10 Years
Financials
Revenue | estimate
$5.3b | $5.5b
EBITDA
$800.7m
EBIT
$778.6m
Net Income
$582.7m
Free Cash Flow | ex SBC
$548.7m | $452.3m
Growth
Revenue | estimate
6.5% | 9.2%
EBITDA
5.8%
EBIT
5.9%
Net Income
8.2%
Free Cash Flow
-2.3%
Margin
Gross
36.5%
EBITDA
15.3%
EBIT
14.8%
Net
11.1%
Free Cash Flow | ex SBC
10.5% | 8.6%
Financial Health
Equity Ratio
43.6%
Return on Equity
21.7%
ROCE
18.0%
ROIC
13.3%
Debt/Equity
0.5
Share-Based Compensation & Dilution
SBC | % of Revenue
$96.4m | 1.8%
SBC as % of FCF
17.6%
SBC Growth 1Y
19.5%
Share Count Growth 1Y
-3.6%
Shareholder Yield
5.4%
More
EPS
$3.4
FCF per Share
$3.3
Short interest
7.6%
Employees
145k
Rev per Employee
$40.0k

Genpact Limited Stock Analysis

Unlock Scores for Free

Analyst Opinions

20 Analysts have issued a Genpact Limited forecast:

10x Buy
50%
9x Hold
45%
1x Sell
5%

Analyst Opinions

20 Analysts have issued a Genpact Limited forecast:

Buy
50%
Hold
45%
Sell
5%

Genpact Limited Events

Upcoming Event
NOV
5
Q3 2026 Earnings Call
TOMORROW
View Past Earnings Reaction
Past Events
AUG
6
Q2 2026 Earnings Call
3 months ago
MAY
18
J.P. Morgan 54th Annual Global Technology
6 months ago
MAY
7
Q1 2026 Earnings Call
6 months ago
FEB
5
Q4 2025 Earnings Call
9 months ago
NOV
6
Q3 2025 Earnings Call
12 months ago

Financial data from Genpact Limited

Jun '26
+/-
%
5,250 5,250
7% 7%
100%
- Direct Costs 3,336 3,336
5% 5%
64%
1,914 1,914
9% 9%
36%
- Selling and Administrative Expenses 1,104 1,104
10% 10%
21%
- Research and Development Expense - -
-
-
801 801
6% 6%
15%
- Depreciation and Amortization 22 22
2% 2%
0%
EBIT (Operating Income) EBIT 779 779
6% 6%
15%
Net Profit 583 583
8% 8%
11%

In millions USD.

Don't miss a Thing! We will send you all news about Genpact Limited directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Genpact Limited Stock News

Neutral
PRNewsWire
●
8 days ago
Recognition reinforces Genpact's position as a Leader in helping CFOs move to Agentic Operations designed to deliver measurable outcomes NEW YORK, Oct. 28, 2026 /PRNewswire/ -- Genpact (NYSE: G), the Agentic Operations company, has been named a Leader in NelsonHall's 2026 NEAT evaluation for Finance and Accounting Transformation . Genpact was recognized as a Leader overall and across all evalua...
Neutral
Business Wire
●
9 days ago
TAMPA, Fla.--(BUSINESS WIRE)--AT&T and Smart Meter are expanding their collaboration aimed at helping healthcare providers maintain connectivity for remote patient monitoring devices in more locations across the United States. As healthcare organizations increasingly rely on connected technologies to support patients managing chronic conditions outside traditional care settings, consistent conn...
Neutral
PRNewsWire
●
17 days ago
The award highlights Genpact's market-leading organic revenue growth as Genpact scales Agentic Operations for global enterprises NEW YORK, Oct. 19, 2026 /PRNewswire/ -- Genpact (NYSE: G), the Agentic Operations company, has received the Growth Honor of the Year (annual revenue USD 5 billion +) in Everest Group's 2026 Elevate Honors, presented at Everest Group's Elevate conference in Dallas. The...
More Genpact Limited News

Company Profile

Genpact Ltd. engages in the business process management, outsourcing, shared services and information outsourcing. The company operates through the following segments: Banking, Capital Markets and Insurance or BCMI, Consumer Goods, Retail, Life Sciences and Healthcare or CGRLH and High Tech, Manufacturing and Services or HMS. The Segment Banking, Capital Markets and Insurance provides operations services for clients in the insurance industry vertical - such as property and casualty insurers, life and annuities insurers, reinsurance providers and insurance brokerage firms - include underwriting, claims management, regulatory reporting, risk and catastrophe modelling, and customer segmentation and loyalty. The Segment Consumer Goods, Retail, Life Sciences and Healthcare provides operations services to supply chain management, order management, trade promotion optimization, and supplier risk management. The Segment and High Tech, Manufacturing and Services provides operations services to these clients include industry-specific solutions for the Industrial Internet of Things (IIoT), order and supply chain management, digital content management and risk management. The company was founded in 1997 by Pramod Bhasin and is headquartered in Hamilton, Bermuda.

Head office Bermuda
CEO Mr. Kalra
Employees 145,000
Founded 1997
Website www.genpact.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today